Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition.
Guzman UH, Martinez-Val A, Ye Z, Damoc E, Arrey TN, Pashkova A, Renuse S, Denisov E, Petzoldt J, Peterson AC, Harking F, Østergaard O, Rydbirk R, Aznar S, Stewart H, Xuan Y, Hermanson D, Horning S, Hock C, Makarov A, Zabrouskov V, Olsen JV. Guzman UH, et al. Among authors: hock c. Nat Biotechnol. 2024 Feb 1. doi: 10.1038/s41587-023-02099-7. Online ahead of print. Nat Biotechnol. 2024. PMID: 38302753
Evaluating the Performance of the Astral Mass Analyzer for Quantitative Proteomics Using Data Independent Acquisition.
Heil LR, Damoc E, Arrey TN, Pashkova A, Denisov E, Petzoldt J, Peterson AC, Hsu C, Searle BC, Shulman N, Riffle M, Connolly B, MacLean BX, Remes PM, Senko MW, Stewart HI, Hock C, Makarov AA, Hermanson D, Zabrouskov V, Wu CC, MacCoss MJ. Heil LR, et al. Among authors: hock c. bioRxiv [Preprint]. 2023 Aug 7:2023.06.03.543570. doi: 10.1101/2023.06.03.543570. bioRxiv. 2023. PMID: 37398334 Free PMC article. Updated. Preprint.
Fast and Deep Phosphoproteome Analysis with the Orbitrap Astral Mass Spectrometer.
Lancaster NM, Sinitcyn P, Forny P, Peters-Clarke TM, Fecher C, Smith AJ, Shishkova E, Arrey TN, Pashkova A, Robinson ML, Arp N, Fan J, Hansen J, Galmozzi A, Serrano LR, Westphall MS, Stewart H, Hock C, Damoc E, Pagliarini DJ, Zabrouskov V, Coon JJ. Lancaster NM, et al. Among authors: hock c. bioRxiv [Preprint]. 2023 Dec 14:2023.11.21.568149. doi: 10.1101/2023.11.21.568149. bioRxiv. 2023. PMID: 38045259 Free PMC article. Preprint.
Crowd control of ions in the Astral analyzer.
Stewart H, Grinfeld D, Petzoldt J, Hagedorn B, Skoblin M, Makarov A, Hock C. Stewart H, et al. Among authors: hock c. J Mass Spectrom. 2024 Apr;59(4):e5006. doi: 10.1002/jms.5006. J Mass Spectrom. 2024. PMID: 38501497
The One Hour Human Proteome.
Serrano LR, Peters-Clarke TM, Arrey TN, Damoc E, Robinson ML, Lancaster NM, Shishkova E, Moss C, Pashkova A, Sinitcyn P, Brademan DR, Quarmby ST, Peterson AC, Zeller M, Hermanson D, Stewart H, Hock C, Makarov A, Zabrouskov V, Coon JJ. Serrano LR, et al. Among authors: hock c. Mol Cell Proteomics. 2024 Apr 3;23(5):100760. doi: 10.1016/j.mcpro.2024.100760. Online ahead of print. Mol Cell Proteomics. 2024. PMID: 38579929 Free article.
Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline.
Wybitul M, Buchmann A, Langer N, Hock C, Treyer V, Gietl A; Alzheimer’s Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing. Wybitul M, et al. Among authors: hock c. Neurobiol Aging. 2024 Jul;139:44-53. doi: 10.1016/j.neurobiolaging.2024.03.007. Epub 2024 Mar 29. Neurobiol Aging. 2024. PMID: 38593527 Free article.
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab.
Chen T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, Curiale GG, Tian Y, Patel D, von Rosenstiel P, von Hehn C, Salloway S, Hock C, Nitsch RM, Haeberlein SB, Sandrock A, Singhal P. Chen T, et al. Among authors: hock c. Alzheimers Dement. 2024 May;20(5):3406-3415. doi: 10.1002/alz.13755. Epub 2024 Apr 3. Alzheimers Dement. 2024. PMID: 38567735 Free PMC article. Clinical Trial.
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2.
Schleicher EM, Gairing SJ, Castven D, Hock CS, Dobbermann H, Heinrich S, Meineck M, Kaps L, Galle PR, Weinmann-Menke J, Nguyen-Tat M, Marquardt JU, Labenz C. Schleicher EM, et al. Among authors: hock cs. Am J Physiol Gastrointest Liver Physiol. 2024 May 1;326(5):G583-G590. doi: 10.1152/ajpgi.00304.2023. Epub 2024 Mar 19. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38502914
333 results